Sanyou Biopharmaceuticals and Sinorda Biomedicine have recently entered into a strategic cooperation agreement to drive their innovative bispecific antibody drug project.
Under this agreement, Sanyou's cutting-edge core technology platform for integrated research and development (R&D) and preclinical development of innovative biological drugs will be combined with Sinorda's extensive experience in preclinical and clinical oncology immunotherapy, along with their world-class "super-trillion innovative biologics discovery platform.
This collaboration aims to collaboratively advance the research and development of the product pipeline. The combined strengths and robust collaboration will create fresh opportunities and establish a pioneering cooperative model between enterprises focused on innovative drug research and development services.
Working together with Sanyou boosts ability to speed up the development of new drugs and turn creative ideas into real treatments more rapidly. This partnership enhances the options available for patients seeking treatment by advancing innovative drug products and make a meaningful contribution to improve human health.
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!